Would you have Underactive Thyroid when you have Multiple Sclerosis?


Underactive thyroid is found among people with Multiple sclerosis, especially for people who are female, 40-49 old, take medication Avonex and have Hypothyroidism. We study 712 people who have Underactive thyroid and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen (latest reports from 423,464 Multiple sclerosis patients)

Underactive Thyroid

Underactive thyroid has been reported by people with osteoporosis, high blood pressure, hypothyroidism, osteopenia, depression (latest reports from 77,090 Underactive thyroid patients).

On Oct, 17, 2016

712 people who have Multiple Sclerosis and Underactive Thyroid are studied.

Number of reports submitted per year:

Would you have Underactive thyroid when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Underactive Thyroid *:

  • female: 91.18 %
  • male: 8.82 %

Age of people who have Multiple Sclerosis and experience Underactive Thyroid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.49 %
  • 20-29: 4.42 %
  • 30-39: 17.18 %
  • 40-49: 30.28 %
  • 50-59: 29.62 %
  • 60+: 18.0 %

Severity of Underactive Thyroid *:

  • least: 0.0 %
  • moderate: 100 %
  • severe: 0.0 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Hypothyroidism (29 people, 4.07%)
  • Hypertension (27 people, 3.79%)
  • Depression (27 people, 3.79%)
  • Anxiety (20 people, 2.81%)
  • Pain (15 people, 2.11%)

Most common drugs for these people *:

  • Avonex (278 people, 39.04%)
  • Rebif (170 people, 23.88%)
  • Tysabri (150 people, 21.07%)
  • Synthroid (54 people, 7.58%)
  • Baclofen (50 people, 7.02%)

Top symptoms for these people *:

  • Fatigue (135 people, 18.96%)
  • Multiple Sclerosis Relapse (109 people, 15.31%)
  • Fall (98 people, 13.76%)
  • Depression (91 people, 12.78%)
  • Influenza Like Illness (81 people, 11.38%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Underactive thyroid and Multiple sclerosis?

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Underactive thyroid

Underactive thyroid

Other conditions that could case Underactive thyroid

Underactive thyroid

Related studies

Can you answer these questions?

More questions for: Multiple sclerosis, Underactive thyroid

You may be interested in these reviews

More reviews for: Multiple sclerosis, Underactive thyroid

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.